Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized medicine and the diagnosis and treatment markets for various disease conditions such as cancer, cardiovascular diseases, neurological disorders, and autoimmune diseases. The applications segment also includes the drug discovery market, which in turn covers submarkets such as drug targets, ADME-TOX profiling, and process quality assurance in drug development.

The biomarker technologies segment is classified into the pre-genomic and post-genomic technology markets. The former includes technologies such as enzyme and metabolite assays, immunodiagnostics, and molecular diagnostics; while the latter includes technologies such as transcriptomics, metabolites and imaging biomarkers. The biomarker services segment is bifurcated into the markets for pre- and post-clinical services such as sample preparation, mRNA analysis and miRNA analysis, antibody development, assay development and production, and validation and reporting.

Our research reports analyze and forecast the revenues for all of these markets; and also provide comprehensive data on the factors affecting market growth, such as regulatory issues on genomics, proteomics, and molecular diagnostics in various geographies.   see less

Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized m ....see more